The use of recombinant human (rh) GH or rhIGF-1 has been shown to increase short-term linear growth in preliminary studies in boys with DMD, but as neither study included any bone outcome measures, further study is required (Rutter et al. 2012, 2020). The gene discussed is GH1; the disease is Duchenne muscular dystrophy.